IBM Milestone Brings MRI Technology to the Nanoscale
Achievement marks significant advance toward the imaging of molecular structures
Using Magnetic Resonance Force Microscopy (MFRM), IBM researchers have demonstrated two-dimensional imaging of objects as small as 90 nanometers, a key advancement on the path of 3D imaging at the atomic scale. Such imaging could ultimately provide a better understanding of how proteins function, which in turn may lead to more efficient drug discovery and development.
MFRM offers imaging sensitivity that is 60,000 times better than current magnetic resonance imaging (MRI) technology. MFRM uses what is known as force detection to overcome the sensitivity limitations of conventional MRI to view structures that would otherwise be too small to be detected.
To achieve this, the research team developed specialized magnetic tips for their microscope, optimizing their ability to manipulate and detect the very weak magnetism of atomic nuclei. Conventional medical MRI typically operates on a scale at least 1,000 times coarser; even the most specialized MRI microscopy is limited to about 3 micrometers, or 3,000 nanometers.
This achievement could eventually have major impact on the study of materials - ranging from proteins and pharmaceuticals to integrated circuits - for which a detailed understanding of the atomic structure is essential. Knowing the exact location of specific atoms within tiny nanoelectronic structures, for example, would enhance designers' insight into manufacture and performance. The ability to directly image the detailed atomic structure of proteins would aid the development of new drugs.
Original publication: H. J. Mamin, M. Poggio, C. L. Degen, D. Rugar; "Nuclear magnetic resonance imaging with 90-nm resolution."; Nature Nanotechnology 2007.
Most read news
Organizations
Other news from the department science
Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.